Example: confidence
Gemcitabine – Capecitabine for Palliative Pancreatic Cancer
Reason for Update:Protocol Development Version: 1 Approved by Consultant: Paul Ross Supersedes: All other versions Date: 05/02/2016 Prepared by: Melanie Dalby 02/02/2016 Checked by …
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
BLADDER CANCER / TRANSITIONAL CELL …
www.londoncanceralliance.nhs.ukBladder Cancer-TCC Regimens v7.01 Approved NWLCN 15Oct13.doc Bl ad er p g 2 of 18 BLADDER CANCER / TRANSITIONAL CELL CARCINOMA Section by: Dr Philip Savage, Professor Jonathan Waxman,Dr Alison Falconer, Dr Simon Stewart.
LCA Haemato-Oncology Clinical Guidelines
www.londoncanceralliance.nhs.ukLCA Haemato-Oncology Clinical Guidelines Acute Leukaemia s and Myeloid Neoplasms. Part 1: Acute Lymphoblastic Leukaemia . April 2015
LCA Haemato-Oncology Clinical Guidelines
www.londoncanceralliance.nhs.ukLCA Haemato-Oncology Clinical Guidelines Acute Leukaemias and Myeloid Neoplasms Part 4: Myeloproliferative Neoplasms April 2015
LA Urological ancers linical Guidelines
www.londoncanceralliance.nhs.ukThese guidelines cover the five tumour sites that make up the vast majority of urological cancers, namely the prostate, bladder, kidneys, testicles and penis.
LCA Haemato-Oncology Clinical Guidelines
www.londoncanceralliance.nhs.ukLCA Haemato-Oncology Clinical Guidelines Acute Leukaemias and Myeloid Neoplasms . Part 2: Acute Myeloid Leukaemia . April 2015
Pan London Guidelines for the Safe Prescribing, …
www.londoncanceralliance.nhs.ukPan London Guidelines for Safe Prescribing, Handling and Administration of Cytotoxic Drugs Version 1.0 Page 1 of 107 Pan London Guidelines for the Safe
LCA Breast Cancer Clinical Guidelines 2016
www.londoncanceralliance.nhs.ukNicola Glover, LCA Survivorship and Mental Health & Psychology project manager and AHP lead (survivorship); Kate Jones and Rebecca Brenn an, AHP representatives on t he LCA breast pathway group;
Subcutaneous Bortezomib (Velcade ), …
www.londoncanceralliance.nhs.ukSubcutaneous Bortezomib (Velcade®), Cyclophosphamide & Dexamethasone (VCD) for Multiple Myeloma Page 1 of 4
LCA Skin Cancer Clinical Guidelines
www.londoncanceralliance.nhs.ukLCA SKIN CANCER CLINICAL GUIDELINES 4 Introduction and Background The National Institute for Health and Care Excellence (NICE) published Improving Outcomes for People with Skin Tumours including Melanoma1 in 2006 (Improving Outcomes Guidance – IOG2) as part of the review of all tumour types, to implement The NHS Cancer Plan. The …
Acute Oncology Services Clinical Guidelines
www.londoncanceralliance.nhs.ukLCA ACUTE ONCOLOGY CLINICAL GUIDELINES 4 widespread implementation of up-to-date and evidence-based management of oncology patients, and will assist in the provision of a consistently high standard of care across the LCA.